Burns Matteson Capital Management’s Tenet Healthcare THC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$563K Buy
3,009
+1,870
+164% +$344K 0.18% 100
2026
Q1
$215K Sell
1,139
-2,671
-70% -$563K 0.08% 183
2025
Q4
$757K Buy
+3,810
New +$770K 0.27% 53
2024
Q3
Sell
-3,485
Closed -$464K 194
2024
Q2
$464K Buy
+3,485
New +$420K 0.29% 61
2023
Q2
Sell
-10,772
Closed -$640K 182
2023
Q1
$640K Buy
10,772
+58
+0.5% +$3.22K 0.41% 57
2022
Q4
$523K Buy
+10,714
New +$495K 0.35% 89
2022
Q3
Sell
-8,633
Closed -$454K 144
2022
Q2
$454K Buy
+8,633
New +$601K 0.32% 82
2021
Q3
Sell
-6,976
Closed -$467K 165
2021
Q2
$467K Buy
+6,976
New +$433K 0.37% 48

Other funds holding THC

Burns Matteson Capital Management's THC Position: Q2 2026 in Review

Burns Matteson Capital Management increased its Tenet Healthcare (THC) stake by 164% in Q2 2026, buying an estimated $344K and bringing the position to 3,009 shares worth $563K. The position accounts for 0.18% of the portfolio, ranked #100.

Burns Matteson Capital Management first reported a position in THC in Q2 2021 and has held it in 8 quarters since. The position peaked at $757K in Q4 2025. 679 funds tracked by Wall St. Rank hold THC as of Q2 2026.

  • Burns Matteson Capital Management held 3,009 shares of Tenet Healthcare worth $563K as of Q2 2026.
  • Burns Matteson Capital Management bought 1,870 Tenet Healthcare shares in Q2 2026, an estimated $344K.
  • Tenet Healthcare made up 0.18% of Burns Matteson Capital Management's portfolio in Q2 2026, its #100 holding.
  • Burns Matteson Capital Management first reported a position in Tenet Healthcare in Q2 2021 and has held it in 8 quarters since.
  • Burns Matteson Capital Management's Tenet Healthcare position peaked at $757K in Q4 2025.
  • 679 funds tracked by Wall St. Rank held Tenet Healthcare as of Q2 2026.

Based on Burns Matteson Capital Management's 13F filing for Q2 2026, filed 17 Jul 2026.